Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PIM1 | P11309 | 5/20 | 0.41 |
| ▸ | CSNK2A2 | P19784 | 5/20 | 0.41 |
| ▸ | CSNK2B | P67870 | 5/20 | 0.41 |
| ▸ | PIM3 | Q86V86 | 5/20 | 0.41 |
| ▸ | PIM2 | Q9P1W9 | 5/20 | 0.41 |
| ▸ | PSMB8 | P28062 | 1/20 | 0.40 |
| ▸ | PARP1 | P09874 | 2/20 | 0.36 |
| ▸ | CHEK1 | O14757 | 1/20 | 0.35 |
| ▸ | DAO | P14920 | 2/20 | 0.35 |
| ▸ | AHR | P35869 | 1/20 | 0.35 |
| ▸ | TTR | P02766 | 2/20 | 0.35 |
| ▸ | PBRM1 | Q86U86 | 1/20 | 0.35 |
| ▸ | CA12 | O43570 | 1/20 | 0.34 |
| ▸ | CA9 | Q16790 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22006833 | 0.77 | AHR (0.42) | PIM1CSNK2A2CSNK2BPIM3PIM2 | |
| SCHEMBL1309845 | 0.75 | ERCC5 (0.54) | PIM1CSNK2A2CSNK2BPIM3PIM2 | |
| SCHEMBL16835579 | 0.71 | GABRP (0.47) | PIM1CSNK2A2CSNK2BPIM3PIM2 | |
| SCHEMBL22006946 | 0.70 | DAO (0.46) | PIM1CSNK2A2CSNK2BPIM3PIM2 | |
| SCHEMBL2497885 | 0.70 | PIM1 (0.54) | PIM1CSNK2A2CSNK2BPIM3PIM2 | |
| SCHEMBL3110872 | 0.68 | CHEK1 (0.55) | PARP1CHEK1DAOPBRM1CA12 | |
| SCHEMBL2922284 | 0.68 | DAO (0.60) | PIM1PARP1CHEK1DAOCA12 | |
| SCHEMBL29734052 | 0.68 | CHEK1 (0.55) | PARP1CHEK1DAOPBRM1CA12 | |
| SCHEMBL7027217 | 0.67 | HTT (0.42) | PARP1CHEK1DAOCA12CA9 | |
| Potassium SCHEMBL3642930 | 0.67 | CHEK1 (0.54) | PARP1CHEK1DAOPBRM1CA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200161564-A1 | ORGANIC COMPOUND, COMPOSITION, ORGANIC OPTOELECTRONIC DEVICE, AND DISPLAY DEVICE | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2020-05-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200161564-A1 | ORGANIC COMPOUND, COMPOSITION, ORGANIC OPTOELECTRONIC DEVICE, AND DISPLAY DEVICE | OXER1, OR10J3, OCIAD1 | PIM1 4316/4885CSNK2A2 880/4885CSNK2B 1076/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.